BIOMAT Database Logo BIOMAT Database Logo

Comparison of blood pressure responses to intra-arterial and intra-venous injections of angiotensin I, angiotensin II and bradykinin. 1998

L J Heller, and D E Mohrman
Department of Medical and Molecular Physiology, University of Minnesota, Duluth School of Medicine, 55812, USA. lheller@d.umn.edu

Because of the reported uneven vascular distribution of the enzyme, angiotensin converting enzyme (ACE), we hypothesized that the magnitude of blood pressure responses to bolus injections of angiotensin I (Ang I) and bradykinin (BK) would be dependent upon the route of administration, i.e., intra-arterial (i.a.) or intra-venous (i.v.). Anesthetized rats with cannulas in the left carotid artery and the right internal jugular vein were given bolus injections of each agent, alternating between the two cannulas. Intra-venous injections of Ang I produced transient increases in arterial pressure that were significantly greater (27 +/- 12%) and longer (7 +/- 7%) than those induced by equimolar i.a. injections within the same preparation. Intra-venous injections of BK produced transient decreases in arterial pressure that were significantly smaller (72 +/- 4%) and shorter (78 +/- 11%) than similar i.a. injections. Unexpectedly, i.v. injections of Ang II also evoked slightly larger transient increases in arterial pressure (11 +/- 4%) than similar i.a. injections. These results suggest that enzymatic alterations of Ang I and BK probably by angiotensin converting enzyme during their initial passage through the pulmonary circulation has a small but significant influence on their pressor effects.

UI MeSH Term Description Entries
D007269 Injections, Intra-Arterial Delivery of drugs into an artery. Injections, Intraarterial,Intra-Arterial Injections,Intraarterial Injections,Injection, Intra-Arterial,Injection, Intraarterial,Injections, Intra Arterial,Intra Arterial Injections,Intra-Arterial Injection,Intraarterial Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001920 Bradykinin A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter. Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,Bradykinin Acetate, (9-D-Arg)-Isomer,Bradykinin Diacetate,Bradykinin Hydrochloride,Bradykinin Triacetate,Bradykinin, (1-D-Arg)-Isomer,Bradykinin, (2-D-Pro)-Isomer,Bradykinin, (2-D-Pro-3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (2-D-Pro-7-D-Pro)-Isomer,Bradykinin, (3-D-Pro)-Isomer,Bradykinin, (3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (5-D-Phe)-Isomer,Bradykinin, (5-D-Phe-8-D-Phe)-Isomer,Bradykinin, (6-D-Ser)-Isomer,Bradykinin, (7-D-Pro)-Isomer,Bradykinin, (8-D-Phe)-Isomer,Bradykinin, (9-D-Arg)-Isomer,Arg Pro Pro Gly Phe Ser Pro Phe Arg
D005260 Female Females
D000803 Angiotensin I A decapeptide that is cleaved from precursor angiotensinogen by RENIN. Angiotensin I has limited biological activity. It is converted to angiotensin II, a potent vasoconstrictor, after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME.
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

L J Heller, and D E Mohrman
Digital vascular responses to intra-arterial injections of bradykinin, kallidin, and eledoisin in man.
August 1966, Circulation,
L J Heller, and D E Mohrman
Intra-arterial and intra-venous blood infusion in hemorrhagic shock; comparison of effects on coronary blood flow and arterial pressure.
May 1953, Journal of the American Medical Association,
L J Heller, and D E Mohrman
Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in man.
September 2000, Cardiovascular research,
L J Heller, and D E Mohrman
Blood pressure responses of rats to angiotensin I and II after exposure to cigarette smoke.
August 1980, Research communications in chemical pathology and pharmacology,
L J Heller, and D E Mohrman
[The influence of intraventricularly administered angiotensin II, bradykinin and eledoisin on arterial blood pressure, respiration and electrocardiogram].
January 1971, Acta biologica et medica Germanica,
L J Heller, and D E Mohrman
Blood pressure responses to angiotensin II following aldosterone and adrenalectomy.
January 1967, Acta physiologica latino americana,
L J Heller, and D E Mohrman
Effect of arterial pressure on drinking and urinary responses to angiotensin II.
January 1988, The American journal of physiology,
L J Heller, and D E Mohrman
Comparison of responses of canine pulmonary artery and vein to angiotensin II, bradykinin and vasopressin.
August 1995, European journal of pharmacology,
L J Heller, and D E Mohrman
Renal hemodynamic responses to increased renal venous pressure: role of angiotensin II.
September 1982, The American journal of physiology,
L J Heller, and D E Mohrman
[Experimental research on intra-renal pressure. I. Method and technic for the measurement of intra-renal pressure. II. Intra-renal pressure in relation to variations of arterial, venous and pyelic pressure].
July 1952, Lo sperimentale,
Copied contents to your clipboard!